Validation Challenges in Single-Use Systems: A Practical Perspective
Walk into most new biologics facilities being built today — in Singapore, South Korea, Incheon, Penang, or Pasir Gudang — and you’ll find single-use systems at the centre of the manufacturing design.
Ensuring Sterility & Integrity in Disposable Systems: What Every Biologics Manufacturer Needs to Know
The biologics manufacturing landscape has changed fundamentally over the past decade. Complex modalities — monoclonal antibodies, gene therapies, cell-based products — demand manufacturing environments where contamination risk is not merely controlled but systematically eliminated.
Is Asia Ready for Fully Single-Use Biomanufacturing Facilities?
Asia’s biopharmaceutical industry is no longer just catching up — in several ways, it is setting the pace. From South Korea’s globally competitive CDMOs to the rapid emergence of biotech clusters across Southeast Asia, the region is investing heavily in biologics manufacturing infrastructure.
Sustainability vs Convenience: The Debate Around Single-Use Systems
As the biopharmaceutical industry continues to evolve, single-use systems (SUS) have become a cornerstone of modern manufacturing. Their ability to improve efficiency, reduce turnaround time, and enable flexible facility design has made them the preferred choice across emerging and established markets alike.
Single-Use Systems in Asia: Trends Shaping the Future of Bioprocessing
Over the past decade, Asia has emerged as one of the fastest-growing hubs for biopharmaceutical manufacturing. Countries across Southeast Asia and South Korea are investing heavily in infrastructure, talent, and innovation to position themselves as global biomanufacturing leaders.